Drugs / BioChaperone® Combo 75/25
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03180710 | Jun → Aug 2017 | type 2 diabetes mellitus | Adocia | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2018-01-25 | Adocia | Results Adocia Announces Positive Topline Data From a Dose-Proportionality Study of BioChaperone® Combo in People with Type 2 Diabetes adocia.com ↗ |
All press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2018-01-25 | Adocia | Adocia Announces Positive Topline Data From a Dose-Proportionality Study of BioChaperone® Combo in People with Type 2 Diabetes adocia.com ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BioChaperone Combo 75/25 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03180710 ↗ |
| Route | Subcutaneous | “Single subcutaneous injection of 0.6 U/kg” NCT03180710 ↗ |